Leila Alland

Leila Alland is a highly experienced consultant and board member in the biomedical field, currently serving as a Consultant at Leila Alland MD Consultancy LLC and a member of the Board of Directors for Jubilant Therapeutics Inc, Radiopharm Theranostics, and Abeona Therapeutics. With a strong background in oncology, Leila Alland has been a Scientific Reviewer for the CPRIT Product Development Award Program since 2017 and a member of the Scientific Advisory Council at the Columbia Center for Radiological Research since 2019. Previous roles include Chief Medical Officer at PMV Pharmaceuticals and Affimed, where Leila Alland advanced innovative therapies focusing on cancer treatment. Leila Alland holds an MD from New York University and a BA from the University of Pennsylvania.